Abstract
Background
Numerous epidemiologic studies have found a close association between obesity and cancer. Dietary fat is a fundamental contributor to obesity and is a risk factor for cancer. Thus far, the impact of dietary olive oil on cancer development remains inconclusive, and little is known about its underlying mechanisms.
Methods
Nude mouse xenograft models were used to examine the effects of high olive oil diet feeding on cervical cancer (CC) development and progression. Cell proliferation, migration and invasion were observed by the methods of EdU incorporation, Wound healing and Transwell assay, separately. RNA-sequencing technology and comprehensive bioinformatics analyses were used to elucidate the molecular processes regulated by dietary fat. Differentially expressed genes (DEGs) were identified and were functionally analyzed by Gene Ontology (GO), Kyoto Enrichment of Genes and Genomes (KEGG). Then, protein–protein interaction (PPI) network and sub-PPI network analyses were conducted using the STRING database and Cytoscape software.
Results
A high olive oil diet aggravated tumourigenesis in an experimental xenograft model of CC. Oleic acid, the main ingredient of olive oil, promoted cell growth and migration in vitro. Transcriptome sequencing analysis of xenograft tumour tissues was then performed to elucidate the regulation of molecular events regulated by dietary fat. Dietary olive oil induced 648 DEGs, comprising 155 up-regulated DEGs and 493 down-regulated DEGs. GO and pathway enrichment analysis revealed that some of the DEGs including EGR1 and FOXN2 were involved in the transcription regulation and others, including TGFB2 and COL4A3 in cell proliferation. The 15 most strongly associated DEGs were selected from the PPI network and hub genes including JUN, TIMP3, OAS1, OASL and EGR1 were confirmed by real-time quantitative PCR analysis.
Conclusions
Our study suggests that a high olive oil diet aggravates CC progression in vivo and in vitro. We provide clues to build a potential link between dietary fat and cancerogenesis and identify areas requiring further investigation.
Electronic supplementary material
The online version of this article (10.1186/s12944-019-1023-6) contains supplementary material, which is available to authorized users.
Keywords: High olive oil diet, Cervical cancer, Transcriptome analysis; differentially expressed genes
Background
Cervical cancer (CC) is the fourth leading cause of cancer-related death among women worldwide with approximately 527,600 new cases each year [1] with about 89% of deaths occurring in less developed countries [2]. The oncogenic types of human papillomavirus (HPV) persistent infection are the most common cause of CC [3]. However, progression from high-risk HPV-positive premalignant lesions to malignant carcinoma seldom occurs [4], indicating additional contributors are required to promote CC’s malignant transformation and progression.
Obesity and lifestyle factors, such as smoking, nutrition and physical activity, are considered risk factors in the development of CC. In recent years, a large body of emerging evidence has elucidated a strong association between obesity and CC morbidity and mortality [5–7]. Dietary fat is a fundamental contributor to obesity [8, 9] and is one of the potential factors thought to link obesity and CC. Accumulating evidence has demonstrated that dietary lipids are associated with various malignant tumours, such as breast cancer, colorectal cancer, pancreatic cancer, and prostate cancer [10–12]. Additionally, recent evidence has suggested that both amount and type of dietary fat are important in the cancer aetiology [13].
Olive oil, a common ingredient of Mediterranean diet [14], has attracted much attention, especially in the last few years. Numerous epidemiological studies have reported that cancer occurrence in the Mediterranean was lower, especially involving in the endometrium, breast, skin, intestine and prostate, suggesting protective effects of olive oil [14–17]. Olive oil exhibits beneficial effects due to various antioxidants, including Vitamin E and phenolic compounds such as tyrosol, hydroxytyrosol, and oleuropein. Moreover, it has been demonstrated that, besides antioxidant ability, olive oil exerts anti-inflammatory and anti-neoplastic activities [18, 19]. It displays anti-tumourigenic properties by promoting apoptosis and cell cycle arrest in various cancers, such as lung, oesophageal and colon cancers [20]. However, contrasting results have been reported to show olive oil’s tumour-enhancing effects. Oleic acid (OA), which constitutes 70–80% of olive oil, promotes cell proliferation and migration in highly metastatic gastric and breast cancer cells in an AMPK-dependent manner [21]. A large population-based case-control study of OA indicated that it may increase the risk of pancreatic cancer [22]. Additionally, a high OA diet exhibits a tumour-enhancing effect in rats by modulating epigenetic patterns [23]. Hence more work is needed to clarify the association between dietary olive oil and cancer.
To assist in clarifying disparate outcomes, we examined the effects of high olive oil diet feeding on CC development and progression using nude mouse xenograft models. We performed a comparative transcription analysis of xenograft tumour samples using RNA-seq technology to detect the differential transcriptomic characteristics. Our findings may provide novel insights into understanding the underlying molecular mechanism between dietary lipids and CC.
Materials and methods
Cell culture and mouse xenograft models
CC HeLa cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal bovine serum (FBS) and 1% penicillin-streptomycin. The cells were grown in a humidified atmosphere with 5% CO2 at 37 °C and were subcultured as needed using trypsin-EDTA. Animal care and experimental procedures were approved by the Animal Care Committees at Chongqing Medical University. Four-week-old athymic male BALB/c-nude mice were fed a control diet (CD; 10 kcal % fat), or a high olive oil diet (OD; 45 kcal % fat) ad libitum until the end of the study (n = 5). The detailed nutritional profiles of the diets are presented in Additional file 1: Table S1. A total of 5 × 106 cells in 200 μl PBS was injected subcutaneously into the left flank of the animals. The tumour dimensions were measured every 4 days, and the volumes were calculated by the standard formula: length×width2/2. All the animals were sacrificed 6 weeks after injection, and the tumours were excised, weighed and treated for histological examination.
Histology and immunohistochemistry (IHC)
Xenograft samples were fixed in 4% paraformaldehyde overnight at 4 °C. Subsequently, after dehydration in ethanol, clearing in xylene, and embedding in paraffin, 5-μm-thick histological sections were obtained. To evaluate tumour heterogeneity and pathological grade, the tissue sections were stained with haematoxylin and eosin (H&E). The IHC procedure was applied according to the instructions of a commercial kit (ZsBio, China). The sections were incubated with anti-proliferating cell nuclear antigen (PCNA) primary antibodies (1:8000; CST, USA) at 4 °C overnight. The IHC results were analysed using a microscope by two separate researchers at 400 × magnification in five randomly selected representative fields.
Cell proliferation assays
For growth curves, HeLa cells were seeded in 96-well plates treated with or without 10 μM OA and were imaged in an IncuCyte (Essen, USA) automated incubator microscope. Pictures were taken every 4 h., and cell confluence was calculated per well using an associated software algorithm. DNA synthesis was determined using a Cell-Light EdU Apollo 643 In Vitro Imaging Kit (RiboBio, China) according to the manufacturer’s instructions. Briefly, the cells were incubated with 50 μM EdU for 1 h. before fixation with 4% paraformaldehyde, permeabilization in 0.3% Triton X-100, and EdU staining. The EdU-positive cells were counted randomly in five fields under a microscope (× 100).
Wound-healing and Transwell migration assays
Wound-healing and Transwell migration assays were performed to evaluate the parallel and vertical migration ability of the cells, respectively. For the wound-healing assay, HeLa cells were plated on 24-well plates, scratched with a pipette tip, and washed with PBS to remove cell debris. Wound closure was observed and photographed at 0, 24 and 48 h. For the Transwell assay, 2 × 104 cells in 100 μl of serum-free medium with or without 10 μM OA were loaded into the upper chamber. Medium containing 10% FBS was added to the lower chamber. After incubation, cells that adhered to the lower surface of the filter were fixed, stained and photographed. Migration was determined by counting the cells in five randomly selected visual fields.
RNA extraction, cDNA construction, and sequencing
Total RNA was prepared from CD-fed mouse xenograft samples and OD-fed mouse xenograft samples using TRIzol reagent (Takara, Japan) according to the manufacturer’s protocol, after which the concentration was measured using the NanoDrop 2000 system (Thermo Fisher, USA). During the quality control steps, the Agilent 2200 Bioanalyser system (Agilent, USA) was used for qualification and quantification of the RNA samples. The RNA extracted with the following criteria was subjected to RNA-Seq analysis: RNA integrity number, ≥7; OD260/OD280, 1.9–2.1; 28S/18S ratio, > 1.8. Next, cDNA was synthesized using the Ion Total RNA-Seq Kit v2 (Life Technologies, USA) according to the manufacturer’s instructions. After library construction, each library preparation was sequenced using the Illumina HiSeq™ 2000 system (Illumina, USA).
Identification of DEGs
After sequencing, raw reads were generated. Next, clean reads were obtained after filtering low-quality reads or reads with an adapter sequence. Further analyses were performed based on those clean reads, and they were mapped to the reference genome in the Ensemble database using Misplacing software [24]. To quantify the gene expression levels, a reliable method considering the gene length for the read counts and effects of the sequencing depth was adopted. Thus, the expression level of each gene was normalized by the reads per kilobase per million (RPKM) [25]. The EBSeq package was implemented to screen DEGs [26], and they were filtered employing a fold-change (FC) method and false discovery rate (FDR) correction, exhibiting an FC > 2 along with FDR < 0.05.
Gene ontology (GO) and pathway enrichment analysis
To analyse the DEGs at the functional level, GO enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the DEGs were conducted. Here, the online tool adopted in this study for GO and KEGG analysis was Database for Annotation, Visualization and Integrated Discovery (DAVID, https://david.ncifcrf.gov/home.jsp) [27]. We submitted the DEGs list into it and selected Homo sapiens in the species column. Finally, the GO terms or KEGG pathways with the cut-off criteria (P < 0.05) were chosen as the enriched function of the DEGs.
Protein-protein interaction (PPI) network and hub gene analysis
To further investigate the molecular mechanism of CC, all DEGs were used to construct the PPI network using the biological online database tool (Search Tool for the Retrieval of Interacting Genes, STRING, http://string-db.org) [28] to determine and predict the interaction among them. A combined score > 0.7 (high confidence score) was considered significant, and then the PPI network was visualized using Cytoscape software (Version 3.5.1) [29]. To evaluate the importance of nodes in the PPI network, the degree centrality of nodes was calculated and utilized in the present study [30] using the CytoNCA plugin [31] in Cytoscape software. The hub genes/proteins, a small number of crucial nodes for the protein interactions in the PPI network, were chosen with a centrality degree > 8. Because a higher k-core score means a more topological central location, subnetworks in the PPI network were explored by k-core scoring using the MCODE plugin in Cytoscape software, and significant subnetworks with a k-core > 6 were considered potential core regulatory networks.
Real-time quantitative PCR (RT-qPCR)
To validate the RNA-Seq results, cDNA was synthesized by reverse transcription using 1 μg of the original RNA sample as described previously. Next, the cDNA products were subjected to 2-step PCR amplification. RT-qPCR using the SYBR Green method was used to detect the gene expression level. β-Actin was chosen as the reference gene, and the expression levels were computed according to the 2-ΔΔCt method. The primer sequences are provided in Additional file 2: Table S2.
Statistical analysis
The data were represented as the means ± SEM. Differences between the two groups were assessed by Student’s t-test, analysed using the SPSS 22.0 software and considered significant at P < 0.05.
Results
High olive oil diet promotes tumour growth in an experimental CC model
HeLa cells were implanted subcutaneously to CD- and OD-fed nude mice to address the effects of dietary olive oil on tumourigenesis. Mice were sacrificed on day 40, and the tumour xenografts were dissected, weighed and photographed (Fig. 1a). Tumour growth over a 6-week time course was increased significantly in the OD group vs. the CD group (Fig. 1b). High olive oil diet also markedly increased the weight of the xenografts by more than 6-fold (Fig. 1c). Furthermore, OD group xenograft tissues exhibited nuclear hyperchromasia and increased nucleus-to-cytoplasmic ratios, representing poor differentiation and higher heterogeneity (Fig. 1d, upper). Likewise, IHC analyses further uncovered a significant increase in PCNA-positive cells in the OD group (Fig. 1d, lower). These data indicated that high olive oil feeding in nude mice can promote tumour cell growth in vivo.
OA promotes CC cell growth and migration in vitro
Because OA (more than 70% enriched in olive oil) is the most important functional nutrient component of olive oil, we next explored the effects of OA on the malignant phenotype of tumour cells in vitro. First, using the IncuCyte-automated incubator-microscope system, we observed a clear increase in cell proliferation following 10 μM OA treatment (Fig. 2a). Next, the EdU assay was used to detect the possible change in DNA synthesis. The results showed that the EdU-positive cells were increased by OA treatment (P < 0.05) compared with the negative control (NC) group (Fig. 2b). Additionally, to investigate the influence of OA on the migration of HeLa cells in vitro, the wound-healing assay and Transwell assay were performed. The results showed that OA treatment markedly enhanced the cell migration ability in HeLa cells (Fig. 2c, d).
Differentially expressed mRNAs under high olive oil diet feeding
To identify the changes in the transcriptional profiles under different nutritive conditions, we selected three xenograft tumour samples from two groups for RNA-seq analysis. The gene expression level was computed and normalized by RPKM. Subsequently, analysis of DEGs was performed as shown in Fig. 3. Based on the cut-off criteria, in total, 648 genes displayed differential expression in the OD group, including 155 up-regulated DEGs and 493 down-regulated DEGs, compared with the control diet. Hierarchical cluster analysis showing systematic variations of the samples revealed that the DEGs could be utilized to accurately distinguish the OD samples from the CD samples (Fig. 4a). Volcano plots were used to assess gene expression variation between the groups (Fig. 4b). These data indicated that the expression of mRNAs under the high olive oil dietary condition differs from that under the control dietary condition.
Functional annotation and pathway enrichment of DEGs
Next, to obtain a more comprehensive understanding and identify the functional categories of the DEGs, the data were clustered through GO analysis in DAVID. The significantly enriched GO terms with a P value < 0.05 that were divided into biological process (BP), cellular component (CC) and molecular function (MF) ontologies are illustrated in Fig. 5. Regarding the BP ontology, comparing the OD with the CD groups, the highly enriched GO terms of up-regulated DEGs were mainly related to positive regulation of transcription (10 genes), G2/M transition of the mitotic cell cycle (5 genes) and cell adhesion (9 genes). Consistently, the down-regulated DEGs were involved in significant subcategories, including negative regulation of cell proliferation (20 genes), negative regulation of viral genome replication (6 genes) and immune response (18 genes). In the CC ontology, we found that the majority of up-regulated DEGs were associated with subcategory named plasma membrane (40 genes) whereas down-regulated DEGs were involved in multiple cell components such as extracellular space (72 genes), extracellular exosome (114 genes) and plasma membrane (114 genes). In the MF ontology of all DEGs, the binding-related items constituted most of the enriched GO categories, including calcium ion binding (12 genes), clathrin binding (3 genes), fibronectin binding (6 genes), and heparin binding (13 genes). Furthermore, according to the KEGG pathway analysis results (data not shown), the up-regulated DEGs were found to be mostly enriched in the Wnt signalling pathway (4 genes), while the dysfunctional pathways enriched in down-regulated DEGs included antigen processing and presentation (7 genes), the P53 signalling pathway (6 genes), and phagosome (10 genes).
PPI network analysis
To further investigate the molecular mechanism of the high olive oil diet-promoted tumour growth and interactive relationships among all DEGs, we mapped the 648 DEGs to the STRING database, and validated interactions with a combined score greater than 0.7 (high confidence) were selected to construct a PPI network. The PPI network consisted of 565 nodes and 401 interactions (Fig. 6a). In the PPI network, 15 proteins, including Jun Proto-Oncogene (JUN), Decorin (DCN), Thrombospondin 1 (THBS1), Major Histocompatibility Complex, Class II, DR alpha (HLA-DRA), Endothelin 1 (EDN1), TIMP Metallopeptidase Inhibitor 3 (TIMP3), Transforming Growth Factor Beta 2 (TGFB2), 2′-5′-Oligoadenylate Synthetase 3 (OAS3), 2′-5′-Oligoadenylate Synthetase Like (OASL), 2′-5′-Oligoadenylate Synthetase 1 (OAS1), Platelet Derived Growth Factor Subunit B (PDGFB), Matrix Metallopeptidase 1 (MMP1), Early Growth Response 1 (EGR1), Syndecan 4 (SDC4) and Serpin Family E Member 1 (SERPINE1), were strongly connected to other proteins (degree centrality more than 8), indicating that they were hub genes (Fig. 6b). These hub genes might play crucial roles in olive oil-induced tumour growth. The hub genes and their corresponding degree are shown in Table 1. Moreover, the whole network was analysed utilizing the cytoscape plugin MCODE. The top 3 significant modules marked A, B and C, respectively, with a k-core more than 6, were selected as subnetworks, and 15 hub genes involved in the modules were marked with different colours (Fig. 7).
Table 1.
No. | Gene ID | Protein Names | Degree | Betweeness | Closeness |
---|---|---|---|---|---|
1 | JUN | Transcription factor AP-1 | 17 | 12,790.9 | 0.0133 |
2 | DCN | Decorin | 13 | 5328.0 | 0.0132 |
3 | THBS1 | Thrombospondin-1 | 13 | 1587.0 | 0.0132 |
4 | HLA-DRA | HLA class II histocompatibility antigen | 13 | 4704.1 | 0.0131 |
5 | TIMP3 | Metalloproteinase inhibitor 3 | 11 | 1142.2 | 0.0132 |
6 | TGFB2 | Transforming growth factor beta-2 | 11 | 1907.1 | 0.0132 |
7 | EDN1 | Endothelin-1 | 11 | 4387.2 | 0.0132 |
8 | PDGFB | Platelet-derived growth factor subunit B | 10 | 1240.2 | 0.0132 |
9 | OAS3 | 2′-5′-oligoadenylate synthase 3 | 10 | 1546.5 | 0.0131 |
10 | OASL | 2′-5′-oligoadenylate synthase-like protein | 10 | 1546.5 | 0.0131 |
11 | OAS1 | 2′-5′-oligoadenylate synthase 1 | 10 | 1546.5 | 0.0131 |
12 | SDC4 | Syndecan-4 | 9 | 2005.1 | 0.0132 |
13 | SERPINE1 | Endothelial plasminogen activator inhibitor | 9 | 3693.0 | 0.0132 |
14 | MMP1 | Matrix metalloproteinase-1 | 9 | 2731.9 | 0.0132 |
15 | EGR1 | Early growth response protein 1 | 9 | 5957.4 | 0.0132 |
Confirmation of DEGs by RT-qPCR
Five DEGs (JUN, TIMP3, OAS1, OASL, and EGR1) were arbitrarily selected to confirm their differential expression levels by RT-qPCR. As shown in Fig. 8, the qPCR results of the DEGs agreed with those of RNA-Seq analysis, suggesting the RNA-Seq data used in the present study were reliable and accurate. Both the OD group and CD group had three independent samples, and all the samples were processed in triplicate.
Discussion
Olive oil, regarded as a key nutraceutical component of the traditional Mediterranean diet, exerts a beneficial impact mainly on the development and progression of cardiovascular risk events [32]. However, in the last two decades, there have been puzzling results regarding the possible role of dietary olive oil in cancer prevention and treatment. In the present study, we showed that feeding nude mice a high olive oil diet enhances xenograft tumour growth and progression. A bioinformatics analysis was performed to explore potential crucial DEGs associated with high olive oil diet. Then an advanced analysis was conducted to give insights into the biological functions and pathways involving DEGs. Finally, by building the PPI, we identified some hub genes and three subnetworks that might play decisive roles in the boosting effect of experimental CC.
As a result, 648 DEGs were screened out, including 155 up-regulated and 493 down-regulated DEGs. The up-regulated DEGs were mainly involved in functions related to positive regulation of transcription, such as EGR1 and Forkhead Box N2 (FOXN2). CC has been proven to be related to the disruption of transcription, including enhanced oncogene expression, loss of function of tumour suppressor genes and DNA repair genes [33]. EGR1, the only up-regulated hub gene in this study, activates expression of some cell cycle-related genes (e.g., cyclin D2 and Mitotic Arrest Deficient Protein 2) [34] and several growth factors (e.g., Platelet Derived Growth Factor Subunit A, Transforming Growth Factor Beta 1 and Insulin- Like Growth Factor 2) [35], suggesting its important role as an oncogene. EGR1 has been linked to some key cellular functions, such as proliferation [36] and migration [37]. Moreover, high levels of EGR1 were seen in CC tissues compared with that in normal tissues, suggesting its role in cervical oncogenesis [38]. The down-regulated DEGs were mainly related to the negative regulation of cell proliferation, such as Collagen Type IV Alpha 3 Chain and TGFB2. Furthermore, enriched KEGG pathways of up-regulated DEGs only included the Wnt signalling pathway. A disturbance in the Wnt signalling pathway has been highly noted in various cancers, including CC [39, 40]. Down-regulated DEGs were mostly associated with antigen processing and presentation. These altered genes and pathways may enhance our understanding of the mechanisms of dietary olive oil-induced tumour progression .
Through PPI network construction, a series of hub genes/proteins has been observed to form a local network, including JUN, DCN, THBS1, HLA-DRA, EDN1, TIMP3, TGFB2, OAS3, OASL, OAS1, PDGFB, MMP1, EGR1, SDC4 and SERPINE1, of which most DEGs have been reported to associate with cancer development. JUN encoding the c-Jun protein is among the hub genes that exhibit the highest degree of connectivity. JUN is widely regarded as an oncogene, which is the most extensively studied protein of the activator protein-1 (AP-1) complex and is involved in numerous cell activities, including proliferation, migration and tumour progression [41]. On the other hand, the c-Jun NH2-terminal kinase (JNK) /c-Jun pathway is an important pro-apoptotic signalling pathway in cancer cells. In our present study, JUN was significantly decreased in the xenografts of olive oil-fed mice. To address the possible role of JUN in CC, we analysed the cervical and endocervical cancers dataset of The Cancer Genome Atlas (TCGA) and found that the expression of JUN was also significantly down-regulated in CC tissues compared with that in normal tissues. The second hub gene, DCN, encoding Decorin, is markedly related to two main themes—maintenance of cellular structure and regulation of signal transduction pathways—culminating in anti-tumourigenic effects [42]. Studies have shown that deficiency of DCN is permissive for tumour development [43], whereas overexpression of DCN could block the cell cycle and decrease the invasive ability of cancer cells [42]. Although numerous applications of DCN as an anticancer therapeutic have been carried out, few studies have addressed the role of DCN in CC. THBS1, the third hub gene, is a 450-kDa homotrimeric matricellular glycoprotein with potent antiangiogenic effects by inhibiting the activity of Vascular Endothelial Growth Factor (VEGF) [44, 45]. Depend on its role to suppress angiogenesis, THBS1 was shown to retard tumour growth and is often found down-regulated in tumour samples [46]. In this study, we speculated that dietary high olive oil intake may contribute to tumourigenesis via JUN, DCN and THBS1-related signalling pathways, thereby maintaining proliferative capacity, anti-apoptosis, and promoting angiogenesis.
Subsequently, subnetwork analysis of the PPI network revealed that 3 clusters of genes representing a more topological central location were associated with CC proliferation and migration. Due to the inclusion of multiple OAS protein family members, the subnetwork that maintained the highest k-core value was associated with viral replication. The OAS proteins, consisting of OAS1/2/3 and OASL protein, were the first interferon-induced anti-viral proteins impeding the translation of viral nucleic acids [47]. The association between HPV and CC has been clearly established [48], and it is widely accepted that the major cause of CC is chronic infection with oncogenic HPV. However, the role of OAS family members during tumour development is not well documented.
Regarding the molecular mechanisms of olive oil and other dietary lipids on cancer, these aspects include: 1) influence on lipid peroxidation and the subsequent oxidative DNA damage, which can modulate inflammation and tumor development; 2) influence on transcription factor activity, gene expression, and signal transduction, which leads to changes in metabolism, cell proliferation, and angiogenesis; 3) alteration of the immune system, which leads to immune function abnormalities and inflammatory cytokine production imbalance [49–51].
Based on these clues, we try to find the potential links between dietary olive oil and the hub genes. Inflammation is a hallmark of cancer [52] and involved in all stages of the malignant process [53]. A high-fat diet can induce chronic inflammation, which in turn may aggravate oxidative stress and lipid peroxidation [54]. TIMP3, listed in the top centrality of down-regulated DEGs, has been shown to regulate TNF functions and modulate inflammatory responses [55]. In addition, the effects of dietary lipids and their metabolites on carcinogenesis may be directly mediated by binding to various nuclear receptors (PPAR, HNF4A) and activating their transcription factor action, or indirectly mediated as the result of changes in the abundance of regulatory transcription factors (SREBP, NFκB) [56]. Hub genes such as JUN and EGR1 are critical transcription factor, which can bind to NFκB and PPARγ respectively to regulate various gene expressions. Furthermore, immune system is critical for tumour control and immune destruction has been recognized as a new hallmark of tumorigenesis [57]. Dietary lipids, especially olive oil, have been shown to modulate the immune and inflammatory responses [58]. Recently, the OAS proteins are connected to innate immune-activated diseases and the activation of the OAS-RNase L axis has emerged as a feature of early immune transcriptome [59] [60]. However, there is no evidence that illuminate the relationship between olive oil and these hub genes. Our further work will conduct to establish the role of dietary olive oil in the control of these hub genes and their regulatory networks.
Conclusions
In conclusion, our study suggests that high olive oil diet aggravates CC progression in vivo and in vitro. A comprehensive bioinformatics analysis showed distinct gene expression patterns between CD-fed mice and OD-fed mice and provides a set of useful hub genes for future investigation into molecular mechanisms and biomarkers.
Additional files
Acknowledgments
Not applicable.
Funding
This research was supported by the National Natural Science Foundation of China (81570517, 81873569, 31571210), the Science and Technology Research Program of Chongqing Municipal Education Commission (Grant No. KJZD-K201800401), National Key R&D Program of China (2018YFC1312700) and the Program for Innovation Team of Higher Education in Chongqing (grant no. CXTDX201601015).
Availability of data and materials
The authors confirm that all materials described in the manuscript are fully available.
to any scientist wishing to use them, without restriction.
Abbreviations
- AP-1
Activator protein-1
- BP
Biological process
- CC
Cellular component
- CC
Cervical cancer
- CD
Control diet
- DAVID
Database for Annotation, Visualization and Integrated Discovery
- DCN
Decorin
- DMEM
Dulbecco’s modified Eagle’s medium
- EDN1
Endothelin 1
- EGR1
Early Growth Response 1
- FBS
Foetal bovine serum
- FC
Fold-change
- FDR
False discovery rate
- FOXN2
Forkhead Box N2
- GO
Gene ontology
- H&E
Haematoxylin and eosin
- HLA-DRA
Major Histocompatibility Complex, Class II, DR Alpha
- HPV
Human papillomavirus
- JNK
c-Jun NH2-terminal kinase
- JUN
Jun proto-oncogene
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- MF
Molecular function
- MMP1
Matrix Metallopeptidase 1
- OA
Oleic acid
- OAS1
2′-5′-Oligoadenylate Synthetase 1
- OAS3
2′-5′-Oligoadenylate Synthetase 3
- OASL
2′-5′-Oligoadenylate Synthetase Like
- OD
Olive oil diet
- PCNA
Proliferating cell nuclear antigen
- PDGFB
Platelet Derived Growth Factor Subunit B
- PPI
Protein-Protein Interaction
- RPKM
Reads per kilobase per million
- RT-qPCR
Real-time quantitative PCR
- SDC4
Syndecan 4
- SERPINE1
Serpin Family E Member 1
- STRING
Search Tool for the Retrieval of Interacting Genes
- TCGA
The Cancer Genome Atlas
- TGFB2
Transforming Growth Factor Beta 2
- THBS1
Thrombospondin 1
- TIMP3
TIMP Metallopeptidase Inhibitor 3
- VEGF
Vascular Endothelial Growth Factor
Authors’ contributions
XYZ, PY, XL, CXS, LW, YC, LZ and HZ performed the experiments. XYZ and PY analyzed the data, prepared figures and contributed to the drafting of the manuscript. ZV, JFM, XZR and YXC supervised this work and edited and revised manuscript. YXC and XZR initiated the project, design the experiments and approved the final version of manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Mouse care and experimental procedures were approved by the Animal Care Committees at Chongqing Medical University.
Consent for publication
All authors agree to publish this article in the Journal of Lipids in Health and Disease.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Xiong Z. Ruan, Email: x.ruan@ucl.ac.uk
Yaxi Chen, Email: chenyaxi@cqmu.edu.cn.
References
- 1.Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72–81. doi: 10.1002/ijc.1571. [DOI] [PubMed] [Google Scholar]
- 2.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi: 10.3322/caac.21387. [DOI] [PubMed] [Google Scholar]
- 3.Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265. doi: 10.1136/jcp.55.4.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382:889–899. doi: 10.1016/S0140-6736(13)60022-7. [DOI] [PubMed] [Google Scholar]
- 5.Maruthur NM, Bolen SD, Brancati FL, Clark JM. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) 2009;17:375–381. doi: 10.1038/oby.2008.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Poorolajal J, Jenabi E. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25:232–238. doi: 10.1097/CEJ.0000000000000164. [DOI] [PubMed] [Google Scholar]
- 7.Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer. 2008;123:1892–1896. doi: 10.1002/ijc.23719. [DOI] [PubMed] [Google Scholar]
- 8.Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr. 1998;68:1157–1173. doi: 10.1093/ajcn/68.6.1157. [DOI] [PubMed] [Google Scholar]
- 9.Walker TB, Parker MJ. Lessons from the war on dietary fat. J Am Coll Nutr. 2014;33:347–351. doi: 10.1080/07315724.2013.870055. [DOI] [PubMed] [Google Scholar]
- 10.Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, Yu MC. Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer. 2009;124:678–686. doi: 10.1002/ijc.23950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005;280:13285–13291. doi: 10.1074/jbc.M410922200. [DOI] [PubMed] [Google Scholar]
- 12.Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132–1141. doi: 10.1016/j.jhep.2009.01.027. [DOI] [PubMed] [Google Scholar]
- 13.Bartsch H, Nair J, Owen RW. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem. 2002;383:915–921. doi: 10.1515/BC.2002.098. [DOI] [PubMed] [Google Scholar]
- 14.Owen RW, Haubner R, Würtele G, Hull WE, Spiegelhalder B, Bartsch H. Olives and olive oil in cancer prevention. Eur J Cancer Prev. 2004;13:319–326. doi: 10.1097/01.cej.0000130221.19480.7e. [DOI] [PubMed] [Google Scholar]
- 15.Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomark Prev. 2000;9:869–873. [PubMed] [Google Scholar]
- 16.Owen RW, Giacosa A, Hull WE, Haubner R, Würtele G, Spiegelhalder B, et al. Olive-oil consumption and health: the possible role of antioxidants. The Lancet Oncology. 2000;1:107–112. doi: 10.1016/S1470-2045(00)00015-2. [DOI] [PubMed] [Google Scholar]
- 17.Harwood JL, Yaqoob P. Nutritional and health aspects of olive oil. 2002. [Google Scholar]
- 18.Waterman E, Lockwood B. Active components and clinical applications of olive oil. Altern Med Rev. 2007;12:331–342. [PubMed] [Google Scholar]
- 19.Casaburi I, Puoci F, Chimento A, Sirianni R, Ruggiero C, Avena P, et al. Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Mol Nutr Food Res. 2013;57:71–83. doi: 10.1002/mnfr.201200503. [DOI] [PubMed] [Google Scholar]
- 20.Rahman MA, Amin AR, Shin DM. Chemopreventive potential of natural compounds in head and neck cancer. Nutr Cancer. 2010;62:973–987. doi: 10.1080/01635581.2010.509538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li S, Zhou T, Li C, Dai Z, Che D, Yao Y, et al. High metastaticgastric and breast cancer cells consume oleic acid in an AMPK dependent manner. PLoS One. 2014;9:e97330. doi: 10.1371/journal.pone.0097330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer. 2010;127:1893–1904. doi: 10.1002/ijc.25208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rodriguez-Miguel C, Moral R, Escrich R, Vela E, Solanas M, Escrich E. The role of dietary extra virgin olive oil and corn oil on the alteration of epigenetic patterns in the rat DMBA-induced breast Cancer model. PLoS One. 2015;10:e0138980. doi: 10.1371/journal.pone.0138980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL, et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 2010;38:e178. doi: 10.1093/nar/gkq622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ali Mortazavi BAW, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5:621–628. doi: 10.1038/nmeth.1226. [DOI] [PubMed] [Google Scholar]
- 26.Leng N, Dawson JA, Thomson JA, Ruotti V, Rissman AI, Smits BM, et al. EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics. 2013;29:1035–1043. doi: 10.1093/bioinformatics/btt087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35:W169–W175. doi: 10.1093/nar/gkm415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–D452. doi: 10.1093/nar/gku1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Doerks T, Copley RR, Schultz J, Ponting CP, Bork P. Cytoscape a software environment for integrated models of biomolecular interaction networks. Genome Res. 2002;12:47–56. doi: 10.1101/gr.203201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411:41–42. doi: 10.1038/35075138. [DOI] [PubMed] [Google Scholar]
- 31.Tang Y, Li M, Wang J, Pan Y, Wu FX. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67–72. doi: 10.1016/j.biosystems.2014.11.005. [DOI] [PubMed] [Google Scholar]
- 32.Kouli GM, Panagiotakos DB, Kyrou I, Magriplis E, Georgousopoulou EN, Chrysohoou C, et al. Olive oil consumption and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA study. Eur J Nutr. 2017. [DOI] [PubMed]
- 33.Rusan M, Li YY, Hammerman PS. Genomic landscape of human papillomavirus-associated cancers. Clin Cancer Res. 2015;21:2009–2019. doi: 10.1158/1078-0432.CCR-14-1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem. 2003;278:11802–11810. doi: 10.1074/jbc.M210279200. [DOI] [PubMed] [Google Scholar]
- 35.Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem. 2000;275:38524–38531. doi: 10.1074/jbc.M005220200. [DOI] [PubMed] [Google Scholar]
- 36.Wang D, Guan MP, Zheng ZJ, Li WQ, Lyv FP, Pang RY, et al. Transcription factor Egr1 is involved in high glucose-induced proliferation and fibrosis in rat glomerular mesangial cells. Cell Physiol Biochem. 2015;36:2093–2107. doi: 10.1159/000430177. [DOI] [PubMed] [Google Scholar]
- 37.Tarcic G, Avraham R, Pines G, Amit I, Shay T, Lu Y, et al. EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J. 2012;26:1582–1592. doi: 10.1096/fj.11-194654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Akutagawa O, Nishi H, Kyo S, Terauchi F, Yamazawa K, Higuma C, et al. Early growth response-1 mediates downregulation of telomerase in cervical cancer. Cancer Sci. 2008;99:1401–1406. doi: 10.1111/j.1349-7006.2008.00835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol. 2004;48:477–487. doi: 10.1387/ijdb.041815jb. [DOI] [PubMed] [Google Scholar]
- 40.Ramos-Solano M, Alvarez-Zavala M, Garcia-Castro B, Jave-Suarez LF, Aguilar-Lemarroy A. Wnt signalling pathway and cervical cancer. Rev Med Inst Mex Seguro Soc. 2015;53(Suppl 2):S218–S224. [PubMed] [Google Scholar]
- 41.Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1) J Med Chem. 2014;57:6930–6948. doi: 10.1021/jm5004733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zhang W, Ge Y, Cheng Q, Zhang Q, Fang L, Zheng J. Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment. Oncotarget. 2018;9:5480–5491. doi: 10.18632/oncotarget.23869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Bi X, Tong C, Dockendorff A, Bancroft L, Gallagher L, Guzman G, et al. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis. 2008;29:1435–1440. doi: 10.1093/carcin/bgn141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem. 1972;247:2723–2731. [PubMed] [Google Scholar]
- 45.Kaur S, Martin-Manso G, Pendrak ML, Garfield SH, Isenberg JS, Roberts DD. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem. 2010;285:38923–38932. doi: 10.1074/jbc.M110.172304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002;6:1–12. doi: 10.1111/j.1582-4934.2002.tb00307.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Eskildsen S, Justesen J, Schierup MH, Hartmann R. Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res. 2003;31:3166–3173. doi: 10.1093/nar/gkg427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63:57–81. doi: 10.3322/caac.21167. [DOI] [PubMed] [Google Scholar]
- 49.Escrich E, Moral R, Grau L, Costa I, Solanas M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res. 2007;51:1279–1292. doi: 10.1002/mnfr.200700213. [DOI] [PubMed] [Google Scholar]
- 50.Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935–945. doi: 10.1093/ajcn/79.6.935. [DOI] [PubMed] [Google Scholar]
- 51.Escrich E, Solanas M, Moral R, Escrich R. Modulatory effects and molecular mechanisms of olive oil and other dietary lipids in breast cancer. Curr Pharm Des. 2011;17:813–830. doi: 10.2174/138161211795428902. [DOI] [PubMed] [Google Scholar]
- 52.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
- 53.Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409–416. doi: 10.1007/s10555-006-9005-3. [DOI] [PubMed] [Google Scholar]
- 54.Khasawneh J, Schulz MD, Walch A, Rozman J, Hrabe de Angelis M, Klingenspor M, et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A. 2009;106:3354–3359. doi: 10.1073/pnas.0802864106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Jackson HW, Hojilla CV, Weiss A, Sanchez OH, Wood GA, Khokha R. Timp3 deficient mice show resistance to developing breast cancer. PLoS One. 2015;10:e0120107. doi: 10.1371/journal.pone.0120107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci. 2004;41:41–78. doi: 10.1080/10408360490278341. [DOI] [PubMed] [Google Scholar]
- 57.O'Sullivan D, Sanin DE. Metabolic interventions in the immune response to cancer. 2019. [DOI] [PubMed] [Google Scholar]
- 58.Stark AH, Madar Z. Olive oil as a functional food: epidemiology and nutritional approaches. Nutr Rev. 2002;60:170–176. doi: 10.1301/002966402320243250. [DOI] [PubMed] [Google Scholar]
- 59.Musumeci G, Castrogiovanni P. Expression of the OAS gene family is highly modulated in subjects affected by juvenile dermatomyositis. Resembling an Immune Response to a dsRNA Virus Infection. 2018;19. [DOI] [PMC free article] [PubMed]
- 60.Dupuis-Maurin V, Brinza L, Baguet J, Plantamura E, Schicklin S, Chambion S, et al. Overexpression of the transcription factor Sp1 activates the OAS-RNAse L-RIG-I pathway. PLoS One. 2015;10:e0118551. doi: 10.1371/journal.pone.0118551. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The authors confirm that all materials described in the manuscript are fully available.
to any scientist wishing to use them, without restriction.